SAG.L

Science Group Plc
Science Group PLC - Issue of share options & PDMR dealing
2nd May 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8978M
Science Group PLC
02 May 2024
 

 

2 May 2024

 

Science Group plc

(the "Company" or "Science Group")

 

Issue of share options and PDMR dealing

 

Science Group plc (AIM:SAG) announces that on 2 May 2024 the Company granted options ("Options") over 330,000 ordinary shares in its share capital to 43 employees of the group under the Company's Performance Share Plan as part of the Company's annual option grant. 

 

The Options will vest after three years from the date of issue and are exercisable at the nominal value of the share of 1 pence per share for a period of seven years from vesting, provided that certain Earnings per Share growth targets have been met in each of the three financial years 2024-2026. 

 

Details of Director and other PDMR option awards are included in the disclosure notices below.  Save for the below, the Directors' beneficial interests in the share capital of the Company remain unchanged and as previously announced.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.      

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Daniel Edwards

2.      

Reason for the notification

a)

Position/status: Group Managing Director

b)

Initial notification/Amendment:  Initial notification

3.      

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Science Group plc

b)

LEI: 2138009OJQT79BDB3E93

4.      

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 1p each.

Identification code: GB00B39GTJ17

b)

Nature of the transaction: Grant of share options

c)

Price(s) and volume(s):

Price(s)

Volume(s)

1p

25,000

d)

Aggregated information:

·      Aggregated volume: 25,000

·      Price: £250

e)

Date of the transaction:  2024-05-02

f)

Place of the transaction: AIMX

 

 

1.        

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Jon Brett

2.      

Reason for the notification

a)

Position/status: Group Finance Director

b)

Initial notification/Amendment:  Initial notification

3.      

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Science Group plc

b)

LEI: 2138009OJQT79BDB3E93

4.      

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 1p each.

Identification code: GB00B39GTJ17

b)

Nature of the transaction: Grant of share options

c)

Price(s) and volume(s):

Price(s)

Volume(s)

1p

20,000

d)

Aggregated information:

·      Aggregated volume: 20,000

·      Price: £200

e)

Date of the transaction:  2024-05-02

f)

Place of the transaction: AIMX

 

1.      

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Sarah Cole

2.      

Reason for the notification

a)

Position/status: Group Legal Counsel & Company Secretary

b)

Initial notification/Amendment:  Initial notification

3.      

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name: Science Group plc

b)

LEI: 2138009OJQT79BDB3E93

4.      

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary shares of 1p each.

Identification code: GB00B39GTJ17

b)

Nature of the transaction: Grant of share options

c)

Price(s) and volume(s):

Price(s)

Volume(s)

1p

20,000

d)

Aggregated information:

·      Aggregated volume: 20,000

·      Price: £200

e)

Date of the transaction:  2024-05-02

f)

Place of the transaction: AIMX

 

 

- Ends -

 

For further information:

Science Group plc


Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

www.sciencegroup.com  

Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)


Nick Adams, Fred Walsh, Richard Short

Tel: +44 (0) 20 7710 7600



Liberum Capital Limited (Joint Broker)


Max Jones, John More

Tel: +44 (0) 20 3100 2000


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFREFILIIS]]>
TwitterFacebookLinkedIn